These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 9701277)

  • 21. Differential effects of oral losartan and enalapril on local venous and systemic pressor responses to angiotensin I and II in healthy men.
    Goldberg MR; de Mey C; Wroblewski JM; Li Q; Schroeter V; Belz GG
    Clin Pharmacol Ther; 1996 Jan; 59(1):72-82. PubMed ID: 8549037
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bradykinin contributes to the systemic hemodynamic effects of chronic angiotensin-converting enzyme inhibition in patients with heart failure.
    Cruden NL; Witherow FN; Webb DJ; Fox KA; Newby DE
    Arterioscler Thromb Vasc Biol; 2004 Jun; 24(6):1043-8. PubMed ID: 15105283
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Effect of losartan and enalapril on urinary excretion of 8-isoprostane in experimental nephrotic syndrome].
    Tesar V; Zima T; Jirsa M; Crkovská J; Stípek S; Vernerová Z; Seráková M
    Cas Lek Cesk; 1999 Oct; 138(18):560-4. PubMed ID: 10596472
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of losartan and benzbromarone on the level of human urate transporter 1 mRNA.
    Nindita Y; Hamada T; Bahrudin U; Hosoyamada M; Ichida K; Iwai C; Urashima S; Kuwabara M; Utami SB; Mizuta E; Yamada K; Igawa O; Shigemasa C; Ninomiya H; Tsuchihashi T; Hisatome I
    Arzneimittelforschung; 2010; 60(4):186-8. PubMed ID: 20486468
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of angiotensin converting enzyme inhibitor and angiotensin II receptor antagonist therapy in hypertensive renal transplant recipients.
    Kim W; Lee S; Kang SK; Yu HC; Cho BH; Park SK
    Transplant Proc; 2002 Dec; 34(8):3223-4. PubMed ID: 12493427
    [No Abstract]   [Full Text] [Related]  

  • 26. The advantages of angiotensin II antagonism.
    Burnier M; Waeber B; Brunner HR
    J Hypertens Suppl; 1994 Jul; 12(2):S7-15. PubMed ID: 7965267
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of antihypertensive therapy on the skeleton: effects of enalapril and AT1 receptor antagonist losartan in female rats.
    Broulík PD; Tesar V; Zima T; Jirsa M
    Physiol Res; 2001; 50(4):353-8. PubMed ID: 11551140
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hypotensive effect of losartan, a nonpeptide angiotensin II receptor antagonist, in essential hypertension.
    Tsunoda K; Abe K; Hagino T; Omata K; Misawa S; Imai Y; Yoshinaga K
    Am J Hypertens; 1993 Jan; 6(1):28-32. PubMed ID: 8427658
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of the renin-angiotensin system does not reduce platelet activity at rest or during stress in hypertension.
    Schwieler JH; Kahan T; Wallén NH; Nussberger J; Hjemdahl P
    J Hypertens; 2013 Aug; 31(8):1676-82. PubMed ID: 23625113
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Non-AT(1)-receptor-mediated protective effect of angiotensin against acute ischaemic stroke in the gerbil.
    Dalmay F; Mazouz H; Allard J; Pesteil F; Achard JM; Fournier A
    J Renin Angiotensin Aldosterone Syst; 2001 Jun; 2(2):103-6. PubMed ID: 11881107
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of losartan on angiotensin II-mediated endothelin and prostanoid excretion in humans.
    Quest DW; Gopalakrishnan V; McNeill JR; Wilson TW
    Am J Hypertens; 2000 Dec; 13(12):1288-94. PubMed ID: 11130773
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A comparative trial of controlled-onset, extended-release verapamil, enalapril, and losartan on blood pressure and heart rate changes.
    Bakris G; Sica D; Ram V; Fagan T; Vaitkus PT; Anders RJ
    Am J Hypertens; 2002 Jan; 15(1 Pt 1):53-7. PubMed ID: 11824861
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Renoprotect and blood pressure lowering effect of low-dose hydrochlorothiazide added to intensive renin-angiotensin inhibition in hypertensive patients with chronic kidney disease.
    Abe M; Okada K; Maruyama T; Matsumoto K
    Int J Clin Pharmacol Ther; 2009 Aug; 47(8):525-32. PubMed ID: 19640361
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative effects of chronic ACE inhibition and AT1 receptor blocked losartan on cardiac hypertrophy and renal function in hypertensive patients.
    De Rosa ML; Cardace P; Rossi M; Baiano A; de Cristofaro A
    J Hum Hypertens; 2002 Feb; 16(2):133-40. PubMed ID: 11850771
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Uric acid-lowering treatment with benzbromarone in patients with heart failure: a double-blind placebo-controlled crossover preliminary study.
    Ogino K; Kato M; Furuse Y; Kinugasa Y; Ishida K; Osaki S; Kinugawa T; Igawa O; Hisatome I; Shigemasa C; Anker SD; Doehner W
    Circ Heart Fail; 2010 Jan; 3(1):73-81. PubMed ID: 19933411
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Renoprotective effect of small doses of losartan and enalapril in patients with primary glomerulonephritis. Short-term observation.
    Tylicki L; Rutkowski P; Renke M; Rutkowski B
    Am J Nephrol; 2002; 22(4):356-62. PubMed ID: 12169868
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of low-dose losartan treatment on persistent microalbuminuria in normotensive type 1 diabetic subjects.
    Açbay O
    J Endocrinol Invest; 2001 Sep; 24(8):608-11. PubMed ID: 11686543
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of Uric Acid Lowering on Renin-Angiotensin-System Activation and Ambulatory BP: A Randomized Controlled Trial.
    McMullan CJ; Borgi L; Fisher N; Curhan G; Forman J
    Clin J Am Soc Nephrol; 2017 May; 12(5):807-816. PubMed ID: 28320765
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of micronized fenofibrate and losartan combination on uric acid metabolism in hypertensive patients with hyperuricemia.
    Elisaf M; Tsimichodimos V; Bairaktari E; Siamopoulos KC
    J Cardiovasc Pharmacol; 1999 Jul; 34(1):60-3. PubMed ID: 10413068
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Autonomic function and baroreflex sensitivity during angiotensin-converting enzyme inhibition or angiotensin II AT-1 receptor blockade in essential hypertensive patients.
    Guasti L; Petrozzino MR; Mainardi LT; Grimoldi P; Zanotta D; Garganico D; Diolisi A; Simoni C; Grandi AM; Gaudio G; Cerutti S; Venco A
    Acta Cardiol; 2001 Oct; 56(5):289-95. PubMed ID: 11712824
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.